OLAPARIB

21443 reported adverse events

Drug classes: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

These side effects are most commonly reported by patients taking OLAPARIB:

# Side effect Count
0 DEATH 4833
1 MALIGNANT NEOPLASM PROGRESSION 2129
2 NAUSEA 1903
3 FATIGUE 1836
4 ANAEMIA 1670
5 OFF LABEL USE 971
6 VOMITING 761
7 NEUROPATHY PERIPHERAL 709
8 DRUG INEFFECTIVE 689
9 ASTHENIA 650
See all common reactions for OLAPARIB

OLAPARIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA RECURRENT 11 0.6471
1 BRCA2 GENE MUTATION 23 0.2421
2 ACUTE ERYTHROID LEUKAEMIA 14 0.2222
3 OVARIAN CANCER RECURRENT 356 0.2214
4 BRCA1 GENE MUTATION 16 0.1818
5 CARBOHYDRATE ANTIGEN 125 5 0.1667
6 ACUTE MEGAKARYOCYTIC LEUKAEMIA 8 0.1455
7 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 12 0.0984
8 ANGIOLIPOMA 6 0.0938
9 TP53 GENE MUTATION 9 0.0928
See all enriched reactions for OLAPARIB